Cargando...
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Liposomal irinotecan (nal-IRI; Onivyde(®); also known as pegylated liposomal irinotecan) has been developed with the aim of maximising anti-tumour efficacy while minimising drug-related toxicities compared with the conventional (non-liposomal) formulation of this topoisomerase 1 inhibitor. In combin...
Gardado en:
| Publicado en: | Drugs |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7347682/ https://ncbi.nlm.nih.gov/pubmed/32557396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01336-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|